Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?

Linked Article: https://doi.org/10.1111/bjd.18015.

Detalles Bibliográficos
Autores principales: Aichelburg, M.C., Tanew, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973000/
https://www.ncbi.nlm.nih.gov/pubmed/31423570
http://dx.doi.org/10.1111/bjd.18355
_version_ 1783489953283440640
author Aichelburg, M.C.
Tanew, A.
author_facet Aichelburg, M.C.
Tanew, A.
author_sort Aichelburg, M.C.
collection PubMed
description Linked Article: https://doi.org/10.1111/bjd.18015.
format Online
Article
Text
id pubmed-6973000
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69730002020-01-27 Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy? Aichelburg, M.C. Tanew, A. Br J Dermatol Commentaries Linked Article: https://doi.org/10.1111/bjd.18015. John Wiley and Sons Inc. 2019-08-18 2020-01 /pmc/articles/PMC6973000/ /pubmed/31423570 http://dx.doi.org/10.1111/bjd.18355 Text en © 2019 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Commentaries
Aichelburg, M.C.
Tanew, A.
Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title_full Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title_fullStr Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title_full_unstemmed Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title_short Secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
title_sort secukinumab without the initial loading dose in the treatment of plaque‐type psoriasis – a simplified dosing regimen at the expense of efficacy?
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973000/
https://www.ncbi.nlm.nih.gov/pubmed/31423570
http://dx.doi.org/10.1111/bjd.18355
work_keys_str_mv AT aichelburgmc secukinumabwithouttheinitialloadingdoseinthetreatmentofplaquetypepsoriasisasimplifieddosingregimenattheexpenseofefficacy
AT tanewa secukinumabwithouttheinitialloadingdoseinthetreatmentofplaquetypepsoriasisasimplifieddosingregimenattheexpenseofefficacy

Ejemplares similares